Cantor Fitzgerald Maintains Overweight on Teradyne, Raises Price Target to $550

Benzinga Newsdesk www.benzinga.com Positive 61.1%

Neg 0% Neu 0% Pos 61.1%

Cantor Fitzgerald analyst C.J. Muse maintains Teradyne (NASDAQ:TER) with a Overweight and raises the price target from $400 to $550.